Dean J. Burkin

3.3k total citations
78 papers, 2.6k citations indexed

About

Dean J. Burkin is a scholar working on Molecular Biology, Immunology and Allergy and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Dean J. Burkin has authored 78 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 19 papers in Immunology and Allergy and 17 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Dean J. Burkin's work include Muscle Physiology and Disorders (43 papers), Cell Adhesion Molecules Research (19 papers) and Cardiomyopathy and Myosin Studies (13 papers). Dean J. Burkin is often cited by papers focused on Muscle Physiology and Disorders (43 papers), Cell Adhesion Molecules Research (19 papers) and Cardiomyopathy and Myosin Studies (13 papers). Dean J. Burkin collaborates with scholars based in United States, New Zealand and United Kingdom. Dean J. Burkin's co-authors include Stephen J. Kaufman, S. J. Kaufman, Jachinta E. Rooney, Marni D. Boppart, Gregory Q. Wallace, Ryan D. Wuebbles, T. E. Broad, Jennifer V. Welser, Bradley L. Hodges and David Kaufman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Circulation Research.

In The Last Decade

Dean J. Burkin

77 papers receiving 2.5k citations

Peers

Countries citing papers authored by Dean J. Burkin

Since Specialization

Citations

This map shows the geographic impact of Dean J. Burkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean J. Burkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean J. Burkin more than expected).

Fields of papers citing papers by Dean J. Burkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean J. Burkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean J. Burkin. The network helps show where Dean J. Burkin may publish in the future.

Co-authorship network of co-authors of Dean J. Burkin

This figure shows the co-authorship network connecting the top 25 collaborators of Dean J. Burkin. A scholar is included among the top collaborators of Dean J. Burkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean J. Burkin. Dean J. Burkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A gene therapy approach for the treatment of limb-girdle muscular dystrophy 2C/R5 2023 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Ryan D. Wuebbles, Dean J. Burkin	1
2	NMRK2 Gene Is Upregulated in Dilated Cardiomyopathy and Required for Cardiac Function and NAD Levels during Aging 2021 ·International Journal of Molecular Sciences ·Cynthia Tannous, Robin Deloux, (unknown), Nathalie Mougenot, Dean J. Burkin, Jocelyne Blanc, Dario Coletti, Gareth G. Lavery, Zhenlin Li, Mathias Mericskay	21
3	Human laminin-111 and laminin-211 protein therapy prevents muscle disease progression in an immunodeficient mouse model of LAMA2-CMD 2020 ·Skeletal Muscle ·(unknown), (unknown), (unknown), (unknown), (unknown), Dean J. Burkin	9
4	Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity 2020 ·Skeletal Muscle ·Takako I. Jones, Guo-Liang Chew, (unknown), (unknown), (unknown), Ryan D. Wuebbles, Dean J. Burkin, Robert K. Bradley, Peter Lloyd Jones	40
5	Improving Reproducibility of Phenotypic Assessments in the DyW Mouse Model of Laminin-α2 Related Congenital Muscular Dystrophy 2017 ·Journal of Neuromuscular Diseases ·Raffaella Willmann, Heather Gordish‐Dressman, Sarina Meinen, Markus A. Rüegg, Qing Yu, Kanneboyina Nagaraju, (unknown), Mahasweta Girgenrath, (unknown), (unknown), Pam M. Van Ry, Laurent Bogdanik, Cathleen Lutz, (unknown), Dean J. Burkin	10
6	ECM‐Related Myopathies and Muscular Dystrophies: Pros and Cons of Protein Therapies 2017 ·Comprehensive physiology ·Pam M. Van Ry, (unknown), (unknown), (unknown), Andreia M. Nunes, Dean J. Burkin	12
7	Evaluation of the behavioral characteristics of the mdx mouse model of duchenne muscular dystrophy through operant conditioning procedures 2017 ·Behavioural Processes ·(unknown), (unknown), Pam M. Van Ry, Dean J. Burkin, Kenneth W. Hunter, Linda J. Hayes	10
8	Heart-specific overexpression of the human short CLC-3 chloride channel isoform limits myocardial ischemia-induced ERP and QT prolongation 2016 ·International Journal of Cardiology ·Ying Yu, Linda Ye, Yi‐Gang Li, Dean J. Burkin, Dayue Darrel Duan	7
9	Laminin-111 improves muscle repair in a mouse model of merosin-deficient congenital muscular dystrophy 2013 ·Human Molecular Genetics ·Pam M. Van Ry, (unknown), Bradley L. Hodges, Dean J. Burkin	55
10	Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy 2011 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Marni D. Boppart, Dean J. Burkin, Stephen J. Kaufman	43
11	Laminin-111 protein therapy prevents muscle disease in the mdx mouse model for Duchenne muscular dystrophy 2009 ·Proceedings of the National Academy of Sciences ·Jachinta E. Rooney, (unknown), Dean J. Burkin	108
12	Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy 2009 ·American Journal Of Pathology ·(unknown), Jianming Liu, Dean J. Burkin, Stephen J. Kaufman	63
13	Myotendinous Junction Defects and Reduced Force Transmission in Mice that Lack α7 Integrin and Utrophin 2009 ·American Journal Of Pathology ·Jennifer V. Welser, Jachinta E. Rooney, (unknown), (unknown), Cherie A. Singer, Rebecca A. Evans, Bryan A. Haines, Dean J. Burkin	40
14	Loss of the α7 Integrin Promotes Extracellular Signal-Regulated Kinase Activation and Altered Vascular Remodeling 2007 ·Circulation Research ·Jennifer V. Welser, (unknown), Cherie A. Singer, (unknown), (unknown), Kathleen D. Keef, William T. Gerthoffer, Dean J. Burkin	38
15	Role for the α7β1 integrin in vascular development and integrity 2005 ·Developmental Dynamics ·(unknown), Jennifer V. Welser, Jachinta E. Rooney, (unknown), Susan Tamowski, William J. Hatton, Dean J. Burkin	76
16	The α7β1 integrin in muscle development and disease 1999 ·Cell and Tissue Research ·Dean J. Burkin, S. J. Kaufman	216
17	Localization and genomic organization of sheep antimicrobial peptide genes 1998 ·Gene ·Kenneth Huttner, Matthew R. Lambeth, Heather R. Burkin, Dean J. Burkin, T. E. Broad	104
18	Sheep CENPB and CENPC genes show a high level of sequence similarity and conserved synteny with their human homologs 1996 ·Cytogenetic and Genome Research ·Dean J. Burkin, C. A. Jones, Heather R. Burkin, (unknown), T. E. Broad	14
19	Physical mapping confirms that sheep chromosome 10 has extensive conserved synteny with cattle chromosome 12 and human chromosome 13 1996 ·Animal Genetics ·T. E. Broad, Matthew R. Lambeth, Dean J. Burkin, C. Jones, P. D. Pearce, D. W. Maher, H.A. Ansari	2
20	Localization of Human Indoleamine 2,3-Dioxygenase (IDO) Gene to the Pericentromeric Region of Human Chromosome 8 1993 ·Genomics ·Dean J. Burkin, K. Sean Kimbro, (unknown), Carol Jones, (unknown), Sohan L. Gupta	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact